Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 3—March 2021
Research

Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May–July 2020

Samira SamiComments to Author , Lara J. Akinbami, Lyle R. Petersen, Addie Crawley, Susan L. Lukacs, Don Weiss, Rebecca A. Henseler, Nga Vuong, Lisa Mackey, Anita Patel, Lisa A. Grohskopf, Beth Maldin Morgenthau, Demetre Daskalakis, and Preeti Pathela
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Sami, A. Patel, L.A. Grohskopf); Centers for Disease Control and Prevention, Hyattsville, Maryland, USA (L.J. Akinbami, S.L. Lukacs); US Public Health Service, Rockville, Maryland, USA (L.J. Akinbami, S.L. Lukacs, L.A. Grohskopf); Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (L.R. Petersen, N. Vuong, L. Mackey); New York City Department of Health and Mental Hygiene, Queens, New York, USA (A. Crawley, D. Weiss, R.A. Henseler, B. Maldin Morgenthau, D. Daskalakis, P. Pathela)

Main Article

Table

Percentage of respondents who were seropositive for SARS-CoV-2 IgG, by demographic and health characteristics, in a study of first responders and public safety personnel, New York City, New York, USA, May 18–July 2, 2020*

Characteristic No. (%)
% Seropositive (95% CI)
Total
22,647 (100.0)
22.5 (21.9–23.0)
Sex
M 17,118 (75.6) 21.9 (21.3–22.5)
F
5,529 (24.4)
24.2 (23.1–25.4)
Age group, y
18–24 795 (3.5) 32.0 (28.7–35.3)
25–34 6,677 (29.5) 26.4 (25.3–27.5)
35–44 8,034 (35.5) 20.2 (19.4–21.1)
45–59 6,328 (27.9) 20.3 (19.4–21.4)
60–64 589 (2.6) 20.7 (17.5–24.2)
>65
224 (1.0)
18.3 (13.5–24.0)
Race/ethnicity
Non-Hispanic White 10,013 (44.2) 18.5 (17.7–19.2)
Non-Hispanic Black 3,292 (14.5) 30.1 (28.5–31.7)
Non-Hispanic Asian 1,647 (7.3) 21.3 (19.4–23.4)
Hispanic or Latino 5,460 (24.1) 26.9 (25.7–28.1)
Non-Hispanic other race† 548 (2.4) 20.3 (17.0–23.9)
Decline to answer
1,687 (7.5)
19.3 (17.4–21.2)
Weight status, n = 22,632‡
Underweight or normal weight 4,048 (17.9) 21.4 (20.2–22.7)
Overweight 10,386 (45.9) 22.1 (21.3–22.9)
Obese 7,500 (33.1) 23.1 (22.1–24.1)
Severely obese
698 (3.1)
27.8 (24.5–31.3)
Housing, n = 22,641
Single family 15,455 (68.3) 21.1 (20.5–21.8)
Multiunit
7,186 (31.7)
25.3 (24.3–26.4)
Residence borough
Outside New York City 8,654 (38.2) 18.3 (17.5–19.2)
Bronx 1,948 (8.6) 28.8 (26.8–30.9)
Brooklyn 3,329 (14.7) 28.0 (26.5–29.5)
Manhattan 1,207 (5.3) 21.4 (19.1–23.8)
Queens 4,834 (21.3) 25.4 (24.2–26.6)
Staten Island
2,675 (11.8)
19.8 (18.3–21.3)
Workplace§
Correctional facility 1,272 (5.6) 36.2 (33.6–39.0)
Emergency medical services 2,418 (10.7) 35.2 (33.3–37.2)
Childcare setting (Regional Enrichment Center) 677 (3.0) 21.3 (18.2–24.6)
Fire services 6,087 (26.9) 20.8 (19.8–21.9)
Police department 11,885 (52.5) 19.8 (19.1–20.5)
Medical examiner office
394 (1.7)
11.7 (8.7–15.3)
Workplace borough
Bronx 3,524 (15.6) 26.8 (25.4–28.3)
Brooklyn 6,075 (26.8) 24.1 (23.1–25.2)
Manhattan 5,755 (25.4) 19.7 (18.6–20.7)
Queens 6,200 (27.4) 21.9 (20.9–23.0)
Staten Island
1,093 (4.8)
17.4 (15.2–19.8)
Exposure to persons who tested positive for SARS-CoV-2‡
Household member 2,393 (10.6) 48.3 (46.3–50.3)
Coworker 14,912 (65.9) 23.7 (23.0–24.3)
Patient 6,502 (28.7) 26.9 (25.8–28.0)
Other person 7,721 (34.1)
26.8 (25.8–27.8)

*BMI, body mass index; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
†Non-Hispanic other race includes Native Hawaiian and other Pacific Islander and American Indian and Alaska Native.
‡Weight status categories defined as underweight or normal weight (BMI <25), overweight (BMI >25 but <30), obese (BMI >30 but <40), and severely obese (BMI >40).
§Workplace and self-reported exposure to persons who tested positive for SARS-CoV-2 are not mutually exclusive.

Main Article

Page created: January 11, 2021
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external